From the Washington Post this morning: “[T]he infrequently voiced reality, stem cell experts confess, is that, of all the diseases that may someday be cured by embryonic stem cell treatments, Alzheimer’s is among the least likely to benefit.”
Share this story
KL
About the Author
Kathryn Jean Lopez is a senior fellow at the National Review Institute and the religion editor of National Review. Sign up for her weekly newsletter here. She is the author of A Year with the Mystics: Visionary Wisdom for Daily Living.
Advertisement
Advertisement





Comments